The Latest Cardiac and Vascular News
IRVINE, Calif., April 26, 2023 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2023. Highlights and Outlook Q1 sales grew 9 percent to $1.46 billion; constant currency1 sales grew 13 percent Q1 TAVR sales grew 8 percent; constant currency sales grew 11 percent Q1 EPS of $0.56; adjusted1 EPS of $0.62 […]
~ Strong start to the year with 1Q23 financial results ~ ~ Executing strategy to accelerate growth ~ PLANO, Texas, April 27, 2023 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended March 31, 2023. First Quarter 2023 Highlights (compared to First Quarter […]
New company name chosen to represent focus on ‘averting’ serious cardiac complications with state-of-the-art Guardian™ monitoring and alerting system President and CEO Tim Moran and Chief Financial Officer Philip Tom to join Executive Chairman Ross Haghighat in leadership roles EATONTOWN, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Angel Medical Systems […]
Ghent, Belgium, 27 April 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces that in the context of the private placement of new shares and new subscription rights that was announced on 24 April 2023 and […]
Q1 2023 reported revenue of $297.6 million, up 8.0% compared to Q1 2022 Q1 2023 constant currency revenue, organic* up 9.8% compared to Q1 2022 Q1 2023 GAAP operating margin of 8.9%, compared to 5.5% in Q1 2022 Q1 2023 non-GAAP operating margin* of 16.1%, compared to 14.6% in Q1 […]
Reports First Quarter Revenues of $11.3 Billion Posts First Quarter GAAP Earnings Per Share of $1.07 and Non-GAAP EPS of $2.05; Includes Net Impact of ($0.01) Per Share for GAAP and Non-GAAP EPS Due to Acquired IPRD Charges and Licensing Income Delivers Strong Revenue Growth of 8% from In-Line Products […]
First-quarter revenue of $3.65 billion decreased 2% on a reported basis and increased 2% on a constant currency basis1 First-quarter U.S. GAAP earnings per share (EPS) totaled $0.09; Adjusted EPS totaled $0.59 Baxter expects full-year 2023 sales growth of 1% to 2% on a reported basis and ~1% on a […]
MARLBOROUGH, Mass., April 26, 2023 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing 12.0 percent on a reported basis, 14.9 percent on an operational1 basis and 14.0 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income […]
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March 31, 2023, and updated its financial guidance for its fiscal year ending September 30, 2023. Second Quarter Fiscal […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the vMap® next-generation arrhythmia mapping technology, today announced former Philips and Biotronik medical technology leader Marlou Janssen and Yale Clinical Professor of Medicine and past American College of Cardiology (ACC) Connecticut Chapter Governor and President Dr. Craig McPherson have joined Vektor’s advisory board. With […]
